Literature DB >> 16371296

Effects of a subdermal levonorgestrel contraceptive implant (Norplant) on serum cholesterol, triglycerides, ALT and AST in Iranian women.

Mohsen Taheri1, Majid Rahimi, Mohammad Naderi, Saied Ghavami, Mojgan Mokhtari, Homaira Rashidi, Mohammad Hashemi.   

Abstract

BACKGROUND: To evaluate the effects of Norplant (36 mg of levonorgestrel, six capsules) on serum cholesterol, triglycerides, alanine transaminase (ALT) and aspartate transminase (AST), we enrolled 465 healthy women from Zahedan, Iran, into a longitudinal study.
MATERIALS AND METHODS: Blood samples were collected after an overnight fast before implant insertion and after 3, 6, 9 and 12 months of use.
RESULTS: Total cholesterol and triglyceride levels did not significantly change during Norplant use. Although there were statistically significant increases in ALT and AST levels during Norplant use, the values were within the reference range.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16371296     DOI: 10.1016/j.contraception.2005.06.065

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  1 in total

1.  Impact of one-rod levonorgestrel implant on the blood chemistry profile.

Authors:  Eka R Gunardi; Raymond Surya; Inayah Syafitri; Yogi Pasidri
Journal:  Sci Rep       Date:  2021-10-11       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.